HPLC Method for Chiral Separation and Quantification of Antidepressant Citalopram and Its Precursor Citadiol

[1]  H. Aboul‐Enein,et al.  Enantioselective separation and determination of citalopram enantiomers in pharmaceutical dosage form and bulk drug using experimental design approach on Chiralcel® OC as a chiral stationary phase , 2011 .

[2]  C. Saka,et al.  Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants , 2011 .

[3]  M. Mone,et al.  Evaluation of Generic Gradients, Sample Pooling and MS Detection as Chiral Resolution Screening Strategies on Diverse Chiral Stationary Phases , 2011 .

[4]  Nora Unceta,et al.  Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites. , 2011, Biomedical chromatography : BMC.

[5]  Ashok Kumar,et al.  Structural elucidation of process-related impurities in escitalopram by LC/ESI-MS and NMR. , 2010, Journal of pharmaceutical and biomedical analysis.

[6]  Yingxiang Du,et al.  Evaluation of the enantioselectivity of glycogen-based dual chiral selector systems towards basic drugs in capillary electrophoresis. , 2010, Journal of chromatography. A.

[7]  Yingxiang Du,et al.  Evaluation of the enantioseparation capability of the novel chiral selector clindamycin phosphate towards basic drugs by micellar electrokinetic chromatography. , 2010, Journal of chromatography. A.

[8]  E. Lesellier.  Retention mechanisms in super/subcritical fluid chromatography on packed columns. , 2009, Journal of chromatography. A.

[9]  Larry T. Taylor,et al.  Supercritical fluid chromatography for the 21st century , 2009 .

[10]  G. Scriba,et al.  Development and validation of a capillary electrophoresis method for the simultaneous determination of impurities of escitalopram including the R-enantiomer. , 2008, Journal of pharmaceutical and biomedical analysis.

[11]  A. Naidu,et al.  Isolation, structural elucidation and characterization of impurities in Cefdinir. , 2007, Journal of pharmaceutical and biomedical analysis.

[12]  R. N. Rao,et al.  Enantiospecific assay of citadiol--a key intermediate of escitalopram by liquid chromatography on Chiralpak AD-H column connected with UV and polarimetric detectors in series. , 2007 .

[13]  P. R. Kumar,et al.  A stability-indicating HPLC assay method for docetaxel. , 2006, Journal of pharmaceutical and biomedical analysis.

[14]  R. Nageswara Rao,et al.  Development and validation of a liquid chromatographic method for determination of enantiomeric purity of citalopram in bulk drugs and pharmaceuticals. , 2006, Journal of pharmaceutical and biomedical analysis.

[15]  E. A. Wilson.  The Work of Antidepressants: Preliminary Notes on How to Build an Alliance Between Feminism and Psychopharmacology , 2006 .

[16]  Ove Wiborg,et al.  The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors , 2003, European Neuropsychopharmacology.

[17]  K. Bogeso,et al.  The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer , 2005, Journal of Neural Transmission / General Section JNT.

[18]  K. Bogeso,et al.  Escitalopram versus citalopram: the surprising role of the R-enantiomer , 2004, Psychopharmacology.

[19]  V. Gotor,et al.  Enzymatic resolution of a quaternary stereogenic centre as the key step in the synthesis of (S)-(+)-citalopram , 2004 .

[20]  C. Sánchez,et al.  The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats , 2003, Neuropharmacology.

[21]  M. Vaswani,et al.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  W. Burke,et al.  Stereoisomers in Psychiatry: The Case of Escitalopram. , 2002, Primary care companion to the Journal of clinical psychiatry.

[23]  B. Carlsson,et al.  Optimization and characterization of the chiral separation of citalopram and its demethylated metabolites by response-surface methodology , 2001 .

[24]  I. Anderson.  The new antidepressants , 1999 .

[25]  P. Baumann.  Pharmacology and pharmacokinetics of citalopram and other SSRIs , 1996, International clinical psychopharmacology.

[26]  J. Larsen,et al.  Serotonin-selective antidepressants. , 2009, Acta pharmacologica et toxicologica.